Global regulatory fragmentation: the critical challenge for drug-device combination products
Year: 2026
Type: article
Abstract: Introduction Drug-device combination products (DDCPs) are becoming increasingly important in modern healthcare, enabling more precise, convenient, and patient-centered treatment through products such as prefilled syringes (PFS), autoinjectors, inhalers, infusion systems, and digitally enabled delivery tools. However, regulatory systems have not evolved at the same pace. Across major markets, these products are defined, classified, and reviewed in different ways, creating fragmented requirements for development, clinical investigation, marketing authorization, and lifecycle management. Methods By employing a structured comparative regulatory approach across major jurisdictions and analyzing publicly available regulatory frameworks, published guidance, and industry case studies, the research is qualitative in nature, reflecting expert consensus among the multi-company author group rather than a quantitative statistical study. Results This paper examines how these regulatory differences create uncertainty, duplication, delays, and additional burden for both developers and authorities, with direct consequences for timely patient access. It highlights key areas of misalignment, including terminology, regulatory pathways, clinical trial expectations, post-approval change management, and the limited use of reliance mechanisms. By comparing major regulatory approaches and illustrating practical examples from different regions, the paper shows that the current landscape is not fit for increasingly complex and globally developed DDCPs. Discussion Based on the results of the research the authors conclude that greater international convergence, clearer terminology, stronger coordination between medicinal product and medical device regulators, and broader use of reliance principles are needed to create a more predictable and efficient framework that supports innovation while protecting patients.
Source: Frontiers in Medicine
Authors: Sarah Adam(Project administration, Writing – original draft, Writing – review & editing), Henri Akouka(Writing – original draft, Writing – review & editing), Prashant Bhatia(Writing – original draft, Writing – review & editing), Fabio Bisordi(Writing – original draft, Writing – review & editing), Katharine Duncan(Writing – original draft, Writing – review & editing), Andreas Emmendoerffer(Writing – original draft, Writing – review & editing), Michael Kuehler(Writing – original draft, Writing – review & editing), Anurag Patel(Writing – original draft, Writing – review & editing), Rumi Young(Writing – original draft, Writing – review & editing)
Language: English
Topic: Healthcare Regulation
Field: Medicine
Domain: Health Sciences
Keywords: drug-device combination products, regulatory fragmentation, regulatory convergence, prefilled syringes, autoinjector, inhaler devices, infusion devices, medical device regulation, regulatory pathways, clinical trial requirements, drug approval, international regulatory coordination, regulatory terminology
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7235221517
